T 1379/21 (Tuberous sclerosis / NOVARTIS) of 31.10.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T137921.20231031
- Date of decision
- 31 October 2023
- Case number
- T 1379/21
- Petition for review of
- -
- Application number
- 07711417.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TUBEROUS SCLEROSIS TREATMENT
- Applicant name
- Novartis Pharma AG
- Opponent name
- Intas Pharmaceuticals Ltd.
Teva Pharmaceutical Industries Ltd.
Stada-Arzneimittel Aktiengesellschaft
Cooke, Richard - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Amendment to case - complexity of amendment
Amendment to case - amendment admitted (no)
Inventive step - main request (no)
Inventive step - auxiliary requests 1-3, 6, 7, 7B (no)
Amendments - auxiliary requests 4, 5, 7A, 8
Amendments - allowable (no) - Catchword
- -
- Cited cases
- T 1320/13
- Citing cases
- -
Order
For these reasons it is decided that:
4. The decision under appeal is set aside.
5. The patent is revoked.